Why is Suraksha Diagnostic Ltd ?
- PAT(Q) At Rs 13.01 cr has Grown at 61.7% (vs previous 4Q average)
- NET SALES(Q) Highest at Rs 87.65 cr
- PBDIT(Q) Highest at Rs 30.44 cr.
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 14.54%, its profits have risen by 2% ; the PEG ratio of the company is 27.9
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
How much should you buy?
- Overall Portfolio exposure to Suraksha Diagno. should be less than 10%
- Overall Portfolio exposure to Healthcare Services should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Suraksha Diagno. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At Rs 13.01 cr has Grown at 61.7% (vs previous 4Q average
Highest at Rs 87.65 cr
Highest at Rs 30.44 cr.
Highest at 34.73%
Highest at Rs 15.44 cr.
Highest at Rs 2.50
At Rs 7.64 cr has Grown at 28.62%
Highest at 0.53 times
Lowest at 13.64 times
Here's what is working for Suraksha Diagno.
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Net Sales (Rs Cr)
Operating Profit (Rs Cr)
Operating Profit to Sales
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
EPS (Rs)
Here's what is not working for Suraksha Diagno.
Interest Paid (Rs cr)
Debt-Equity Ratio
Debtors Turnover Ratio
Non Operating Income






